Lilly's Axiron Launched in the US Zacks.com Eli Lilly acquired exclusive worldwide rights from Australian company, Acrux, to commercialize Axiron in March 2010. Per the terms of the deal, Eli Lilly made an upfront payment of $50 million and $3 million on the transfer of manufacturing assets. ... |
Wednesday, April 6, 2011
Lilly's Axiron Launched in the US - Zacks.com
http://www.firtinaweb.com/user_detail.php?u=tikannisa
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment